Intellia Therapeutics, Inc.
Long
Updated

NTLA long crispr/cas9

445
buying NTLA as long term investment in crispr/cas9 technology.
Trade active
Note
bottom here would paint this channel
snapshot
Note
CRISPR stocks soar after chinese scientists start to crispr a human for the first time
Note
added to position in this last dip, inv h+s, crispr hot!!
Note
dump it -> go edit
Trade closed manually

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.